Murnaghan K, Vasmant D, Bensman A (1984) Pulse methylprednisolone therapy in severe idiopathic childhood nephrotic syndrome. Acta Paediatr 73:733–739. https://doi.org/10.1111/j.1651-2227.1984.tb17767.x

Article  CAS  Google Scholar 

Letavernier B, Letavernier E, Leroy S, Baudet-Bonneville V, Bensman A, Ulinski T (2008) Prediction of high-degree steroid dependency in pediatric idiopathic nephrotic syndrome. Pediatr Nephrol 23:2221–2226. https://doi.org/10.1007/s00467-008-0914-y

Article  PubMed  Google Scholar 

Qader MA, Vivarelli M (2023) Children with steroid dependent nephrotic syndrome: rituximab or tacrolimus? It’s All in the Timing. Kidney Int Rep 8:1708–1710. https://doi.org/10.1016/j.ekir.2023.07.016

Article  PubMed  PubMed Central  Google Scholar 

Sellier-Leclerc A-L, Macher M-A, Loirat C, Guérin V, Watier H, Peuchmaur M, Baudouin V, Deschênes G (2010) Rituximab efficiency in children with steroid-dependent nephrotic syndrome. Pediatr Nephrol 25:1109–1115. https://doi.org/10.1007/s00467-010-1465-6

Article  PubMed  Google Scholar 

Sinha A, Bagga A, Gulati A, Hari P (2012) Short-term efficacy of rituximab versus tacrolimus in steroid-dependent nephrotic syndrome. Pediatr Nephrol 27:235–241. https://doi.org/10.1007/s00467-011-1997-4

Article  PubMed  Google Scholar 

Trautmann A, Boyer O, Hodson E, Bagga A, Gipson DS, Samuel S, Wetzels J, Alhasan K, Banerjee S, Bhimma R, Bonilla-Felix M, Cano F, Christian M, Hahn D, Kang HG, Nakanishi K, Safouh H, Trachtman H, Xu H, Cook W, Vivarelli M, Haffner D, on behalf of the International Pediatric Nephrology Association, Bouts A, Dossier C, Emma F, Kemper M, Topaloglu R, Waters A, Thorsten Weber L, Zurowska A, Gibson KL, Greenbaum L, Massengill S, Selewski D, Srivastava T, Wang C, Wenderfer S, Johnstone L, Larkins N, Wong W, Alba AA, Ha TS, Mokham M, Zhong X, Hamada R, Iijima K, Ishikura K, Nozu K, Bresolin N, De Jesus Gonzalez N, Restrepo J, Anochie I, McCulloch M (2023) IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome. Pediatr Nephrol 38:877–919. https://doi.org/10.1007/s00467-022-05739-3

Hari P, Bagga A, Mantan M (2004) Short term efficacy of intravenous dexamethasone and methylprednisolone therapy in steroid resistant nephrotic syndrome. Indian Pediatr 41:993–1000

PubMed  Google Scholar 

Shenoy M, Plant ND, Lewis MA, Bradbury MG, Lennon R, Webb NJA (2010) Intravenous methylprednisolone in idiopathic childhood nephrotic syndrome. Pediatr Nephrol 25:899–903. https://doi.org/10.1007/s00467-009-1417-1

Article  PubMed  PubMed Central  Google Scholar 

Webb NJ, Woolley RL, Lambe T, Frew E, Brettell EA, Barsoum EN, Trompeter RS, Cummins C, Wheatley K, Ives NJ (2019) Sixteen-week versus standard eight-week prednisolone therapy for childhood nephrotic syndrome: the PREDNOS RCT. Health Technol Assess 23:1–108. https://doi.org/10.3310/hta23260

Article  PubMed  PubMed Central  Google Scholar 

Ishikura K, Ikeda M, Hamasaki Y, Hataya H, Nishimura G, Hiramoto R, Honda M (2008) Nephrotic state as a risk factor for developing posterior reversible encephalopathy syndrome in paediatric patients with nephrotic syndrome. Nephrol Dial Transplant 23:2531–2536. https://doi.org/10.1093/ndt/gfn013

Article  PubMed  Google Scholar 

Delbet JD, Aoun B, Buob D, Degheili J, Brocheriou I, Ulinski T (2019) Infrequent tacrolimus-induced nephrotoxicity in French patients with steroid-dependent nephrotic syndrome. Pediatr Nephrol 34:2605–2608. https://doi.org/10.1007/s00467-019-04343-2

Article  PubMed  Google Scholar 

Dossier C, Delbet J-D, Boyer O, Daoud P, Mesples B, Pellegrino B, See H, Benoist G, Chace A, Larakeb A, Hogan J, Deschênes G (2019) Five-year outcome of children with idiopathic nephrotic syndrome: the NEPHROVIR population-based cohort study. Pediatr Nephrol 34:671–678. https://doi.org/10.1007/s00467-018-4149-2

Article  PubMed  Google Scholar 

Van Husen M, Kemper MJ (2011) New therapies in steroid-sensitive and steroid-resistant idiopathic nephrotic syndrome. Pediatr Nephrol 26:881–892. https://doi.org/10.1007/s00467-010-1717-5

Article  PubMed  Google Scholar 

Dossier C, Bonneric S, Baudouin V, Kwon T, Prim B, Cambier A, Couderc A, Moreau C, Deschenes G, Hogan J (2023) Obinutuzumab in frequently relapsing and steroid-dependent nephrotic syndrome in children. Clin J Am Soc Nephrol 18:1555–1562. https://doi.org/10.2215/CJN.0000000000000288

Article  PubMed  PubMed Central  Google Scholar